JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has issued an announcement.
JOINN Laboratories (China) Co., Ltd. has announced a final cash dividend of RMB 0.03 per share for the financial year ending December 31, 2024, with the payment expected by August 31, 2025. The announcement highlights the company’s commitment to returning value to shareholders, while also detailing the withholding tax implications for non-resident enterprise shareholders, reflecting the company’s adherence to regulatory tax requirements.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. operates within the pharmaceutical and biotechnology industry, focusing on providing laboratory services and solutions for drug development and testing. The company is known for its expertise in preclinical research and development, catering primarily to pharmaceutical companies seeking to advance their drug discovery and development processes.
YTD Price Performance: 71.12%
Average Trading Volume: 2,560,800
Technical Sentiment Signal: Sell
Current Market Cap: HK$16.72B
For detailed information about 6127 stock, go to TipRanks’ Stock Analysis page.